## **What is the HCPCS code J0129 for?**
The HCPCS code J0129 is a J code, and one of many that's meant to designate the provision of an injected medication. For J0129, what is designated is the provision of an abatacept injection, specifically every 10 mg dose of it. It also comes with a descriptor stating that it can be used for Medicare when it's administered under the direct supervision of a physician, but not when it's self-administered.
Abatacept is an immune system modulator. What it does is that it interferes with the activation of T lymphocytes. By interfering with this, it reduces autoimmune-driven inflammation, which, in turn, alleviates symptoms associated with the inflammation, joint pain, and prevents long-term joint damage.
This kind of injection is provided to patients with certain autoimmune conditions, such as polyarticular juvenile idiopathic arthritis, psoriatic arthritis, and rheumatoid arthritis.
This FDA-approved medicine comes in both subcutaneous and intravenous formulations, so it can be used for subcutaneous administration and IV administration/intravenous infusion. It's also not for chemotherapy administration, nor is it a diagnostic injection. The injection tied to this specific code has a subcutaneous formulation and is administered subcutaneously.
## **Documentation requirements for J0129**
As with any HCPCS code, it's important that you have sufficient documentation that satisfies the coding requirements set by your insurer, as well as related policy articles and local coverage determinations. Here are examples of what you need:
- The patient's full name
- The full names and credentials of the healthcare professionals handling the patient
- The name, address, and type of facility where the injection was administered
- Physician's order
- The relevant information and indications related to your patient's medical record and current condition to justify medical necessity
- Drug information (e.g., drug name, total dosage administered, administration route, lot number, expiration date, manufacturer, National Drug Code, etc.)
- Relevant tests (blood tests, diagnostic tests) that provide information on the patient's immune status
## **Billing requirements for J0129**
Besides the documentation requirements above, please make sure to take note of or have the following:
- 10 mg = 1 unit of service
- Use the appropriate ICD codes related to your patient's condition
- Use CPT code 96372 since this is a subcutaneous injection. If the IV formulation is used, the correct administration codes would be from the IV infusion series (e.g., CPT 96365 for a non-chemo initial IV infusion).
- Use either of two modifiers: JW if there's unused medication in a vial (wastage), or JZ if there's no unused medication.
- Covered under Medicare Part B (when medically necessary and properly documented)
## **Other similar codes**
- **J1438** - Injection, etanercept, 25 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- **J0717** - Injection, certolizumab pegol, 1 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- **J0130** - Injection abciximab, 10 mg
- **J9022** - Injection, atezolizumab, 10 mg
- **J9312** - Injection, rituximab, 10 mg
Frequently asked questions